PubRank

Steven Johnson

Author PubWeight™ 67.97‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Efficacy and safety of the monoclonal anti-tumor necrosis factor antibody F(ab')2 fragment afelimomab in patients with severe sepsis and elevated interleukin-6 levels. Crit Care Med 2004 3.61
2 Neisseria meningitidis recruits factor H using protein mimicry of host carbohydrates. Nature 2009 2.81
3 A conserved face of the Jagged/Serrate DSL domain is involved in Notch trans-activation and cis-inhibition. Nat Struct Mol Biol 2008 2.22
4 Molecular model of a type III secretion system needle: Implications for host-cell sensing. Proc Natl Acad Sci U S A 2006 2.16
5 Structural basis for complement factor H linked age-related macular degeneration. J Exp Med 2007 2.02
6 Three-dimensional reconstruction of the Shigella T3SS transmembrane regions reveals 12-fold symmetry and novel features throughout. Nat Struct Mol Biol 2009 1.70
7 Dimerization of complement factor H-related proteins modulates complement activation in vivo. Proc Natl Acad Sci U S A 2013 1.63
8 What's the point of the type III secretion system needle? Proc Natl Acad Sci U S A 2008 1.58
9 Frequency of CHEK2*1100delC in New York breast cancer cases and controls. BMC Med Genet 2003 1.43
10 Semaphorin-7A is an erythrocyte receptor for P. falciparum merozoite-specific TRAP homolog, MTRAP. PLoS Pathog 2012 1.29
11 Timing is everything: the regulation of type III secretion. Cell Mol Life Sci 2009 1.27
12 Architecture of the major component of the type III secretion system export apparatus. Nat Struct Mol Biol 2012 1.24
13 Structure of the TatC core of the twin-arginine protein transport system. Nature 2012 1.23
14 Defining a protective epitope on factor H binding protein, a key meningococcal virulence factor and vaccine antigen. Proc Natl Acad Sci U S A 2013 1.16
15 Crystal structure of Spa40, the specificity switch for the Shigella flexneri type III secretion system. Mol Microbiol 2008 1.12
16 Structural basis for complement factor I control and its disease-associated sequence polymorphisms. Proc Natl Acad Sci U S A 2011 1.12
17 The structure of OMCI, a novel lipocalin inhibitor of the complement system. J Mol Biol 2007 1.09
18 Expression, purification, crystallization and preliminary crystallographic analysis of MxiH, a subunit of the Shigella flexneri type III secretion system needle. Acta Crystallogr Sect F Struct Biol Cryst Commun 2006 1.08
19 Crystal structures of the CPAP/STIL complex reveal its role in centriole assembly and human microcephaly. Elife 2013 1.07
20 Identification of minor inner-membrane components of the Shigella type III secretion system 'needle complex'. Microbiology 2007 1.06
21 Quantitative volumetric breast imaging with 3D inverse scatter computed tomography. Conf Proc IEEE Eng Med Biol Soc 2012 1.04
22 The extreme C terminus of Shigella flexneri IpaB is required for regulation of type III secretion, needle tip composition, and binding. Infect Immun 2010 1.01
23 Fungicide-induced declines of freshwater biodiversity modify ecosystem functions and services. Ecol Lett 2012 0.98
24 Expression, purification, crystallization and preliminary crystallographic analysis of BipD, a component of the Burkholderia pseudomallei type III secretion system. Acta Crystallogr Sect F Struct Biol Cryst Commun 2006 0.98
25 Pneumatosis Intestinalis Predictive Evaluation Study (PIPES): a multicenter epidemiologic study of the Eastern Association for the Surgery of Trauma. J Trauma Acute Care Surg 2013 0.98
26 Ongoing pain despite aggressive opioid pain management among persons with HIV. Clin J Pain 2010 0.97
27 Structures of the Shigella flexneri type 3 secretion system protein MxiC reveal conformational variability amongst homologues. J Mol Biol 2008 0.96
28 Structures of CD200/CD200 receptor family and implications for topology, regulation, and evolution. Structure 2013 0.95
29 Nonfunctional variant 3 factor H binding proteins as meningococcal vaccine candidates. Infect Immun 2013 0.95
30 Electrical protein detection in cell lysates using high-density peptide-aptamer microarrays. J Biol 2008 0.93
31 Biochemical analysis of the Plasmodium falciparum erythrocyte-binding antigen-175 (EBA175)-glycophorin-A interaction: implications for vaccine design. J Biol Chem 2013 0.92
32 Excessive activity of cathepsin K is associated with cartilage defects in a zebrafish model of mucolipidosis II. Dis Model Mech 2011 0.92
33 Shigella flexneri Spa15 crystal structure verified in solution by double electron electron resonance. J Mol Biol 2010 0.91
34 Polymorphisms in the human inhibitory signal-regulatory protein α do not affect binding to its ligand CD47. J Biol Chem 2014 0.90
35 Slow-light, band-edge waveguides for tunable time delays. Opt Express 2005 0.90
36 High-resolution structures of bacterially expressed soluble human CD59. Acta Crystallogr Sect F Struct Biol Cryst Commun 2007 0.90
37 Identification of false-positive QuantiFERON-TB Gold In-Tube assays by repeat testing in HIV-infected patients at low risk for tuberculosis. Clin Infect Dis 2011 0.89
38 Expression, purification, cocrystallization and preliminary crystallographic analysis of sucrose octasulfate/human complement regulator factor H SCRs 6-8. Acta Crystallogr Sect F Struct Biol Cryst Commun 2007 0.89
39 Structural and functional studies on the N-terminal domain of the Shigella type III secretion protein MxiG. J Biol Chem 2011 0.88
40 Distinct binding and immunogenic properties of the gonococcal homologue of meningococcal factor h binding protein. PLoS Pathog 2013 0.85
41 High-Q enhancement of attractive and repulsive optical forces between coupled whispering-gallery- mode resonators. Opt Express 2005 0.85
42 SepL resembles an aberrant effector in binding to a class 1 type III secretion chaperone and carrying an N-terminal secretion signal. J Bacteriol 2010 0.85
43 Objective and subjective responses to a mechanical external nasal dilator in healthy children and children with nasal congestion. Allergy Asthma Proc 2015 0.84
44 Secretory cell hyperplasia and defects in Notch activity in a mouse model of leukocyte adhesion deficiency type II. Gastroenterology 2009 0.84
45 Structures of the rat complement regulator CrrY. Acta Crystallogr Sect F Struct Biol Cryst Commun 2011 0.84
46 Abnormal accumulation and recycling of glycoproteins visualized in Niemann-Pick type C cells using the chemical reporter strategy. Proc Natl Acad Sci U S A 2013 0.82
47 With phases: how two wrongs can sometimes make a right. Acta Crystallogr D Biol Crystallogr 2010 0.81
48 Benzotriazinone and benzopyrimidinone derivatives as potent positive allosteric AMPA receptor modulators. Bioorg Med Chem Lett 2011 0.81
49 On-surface assembly of coiled-coil heterodimers. Langmuir 2012 0.81
50 Novel poxvirus in big brown bats, northwestern United States. Emerg Infect Dis 2013 0.80
51 Variables associated with decreasing pain among persons living with human immunodeficiency virus: a longitudinal follow-up study. Clin J Pain 2012 0.80
52 A case of community-acquired Acinetobacter junii-johnsonii cellulitis. Biomedica 2012 0.80
53 ErpC, a member of the complement regulator-acquiring family of surface proteins from Borrelia burgdorferi, possesses an architecture previously unseen in this protein family. Acta Crystallogr Sect F Struct Biol Cryst Commun 2013 0.79
54 Putting the structure into complement. Immunobiology 2012 0.79
55 Improving IV iron and anemia management in the hemodialysis setting: a collaborative CQI approach. Nephrol Nurs J 2007 0.78
56 Safety of drotrecogin alfa (activated) in surgical patients with severe sepsis. Surg Infect (Larchmt) 2004 0.78
57 Tetartohedral twinning could happen to you too. Acta Crystallogr D Biol Crystallogr 2012 0.77
58 Coral reef disturbance and recovery dynamics differ across gradients of localized stressors in the Mariana Islands. PLoS One 2014 0.77
59 Low-fractional oxygen concentration continuous positive airway pressure is effective in the prehospital setting. Prehosp Emerg Care 2011 0.77
60 Crystal structure and functional characterization of the complement regulator mannose-binding lectin (MBL)/ficolin-associated protein-1 (MAP-1). J Biol Chem 2012 0.77
61 Development of a murine hematopoietic progenitor complementary DNA microarray using a subtracted complementary DNA library. Blood 2002 0.77
62 Mislocalization of large ARF-GEFs as a potential mechanism for BFA resistance in COG-deficient cells. Exp Cell Res 2011 0.76
63 Geiger-mode avalanche photodiode ladar receiver performance characteristics and detection statistics. Appl Opt 2009 0.75
64 Geometric variations in high index-contrast waveguides, coupled mode theory in curvilinear coordinates. Opt Express 2002 0.75
65 Breeding in America: Neglected tropical diseases taking hold in U.S. Mod Healthc 2015 0.75
66 Organizing for the 'second curve': combining health plans and provider systems. Healthc Financ Manage 2015 0.75
67 Dispersion tailoring and compensation by modal interactions in OmniGuide fibers. Opt Express 2003 0.75
68 Pyogranuloma caused by Mycobacterium asiaticum infection in a steer. J Vet Diagn Invest 2005 0.75
69 Do adjusted clinical groups eliminate incentives for HMOs to avoid substance abusers? Evidence from the Maryland Medicaid HealthChoice program. J Behav Health Serv Res 2003 0.75
70 A randomized trial comparing metallic and absorbable staples for closure of a Pfannenstiel incision for cesarean delivery. Am J Obstet Gynecol 2013 0.75
71 Inhibition of tumor cell proliferation by thieno[2,3-d]pyrimidin-4(1H)-one-based analogs. Bioorg Med Chem Lett 2005 0.75
72 Designing a healing environment. Health Facil Manage 2006 0.75
73 Nano-scale photonic crystal microcavity characterization with an all-fiber based 1.2 - 2.0 mum supercontinuum. Opt Express 2005 0.75
74 Quantitative characterization of higher-order mode converters in weakly multimoded fibers. Opt Express 2003 0.75
75 Optical bistability and cutoff solitons in photonic bandgap fibers. Opt Express 2004 0.75
76 Negative refraction without negative index in metallic photonic crystals. Opt Express 2003 0.75
77 Re:imagine: a report on the UHC Annual Conference 2012. Am J Med Qual 2013 0.75